CTVA
Corteva Inc
NYSE · Chemicals
$72.60
+0.13 (+0.18%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 17.26B | 17.27B | 25.14B | 22.74B | 27.03B |
| Net Income | 1.08B | 977.38M | 2.57B | 2.33B | 2.99B |
| EPS | — | — | — | — | — |
| Profit Margin | 6.3% | 6.0% | 10.2% | 10.2% | 11.1% |
| Rev Growth | -0.1% | -0.1% | +24.8% | -6.0% | +20.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 2.37B | 2.37B | 8.03B | 7.32B | 7.03B |
| Total Equity | 22.16B | 22.16B | 26.36B | 27.86B | 25.08B |
| D/E Ratio | 0.11 | 0.11 | 0.30 | 0.26 | 0.28 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | 2.49B | 2.37B | 4.57B | 4.01B | 5.54B |
| Free Cash Flow | — | — | 3.09B | 2.20B | 2.48B |